319 related articles for article (PubMed ID: 25564106)
1. HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles.
Côrtes FH; Passaes CP; Bello G; Teixeira SL; Vorsatz C; Babic D; Sharkey M; Grinsztejn B; Veloso V; Stevenson M; Morgado MG
J Acquir Immune Defic Syndr; 2015 Apr; 68(4):377-385. PubMed ID: 25564106
[TBL] [Abstract][Full Text] [Related]
2. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
[TBL] [Abstract][Full Text] [Related]
3. Brief Report: Identification of Elite and Viremic Controllers From a Large Urban HIV Ambulatory Center in Kampala, Uganda.
Kayongo A; Gonzalo-Gil E; Gümüşgöz E; Niwaha AJ; Semitala F; Kalyesubula R; Bagaya BS; Joloba ML; Sutton RE
J Acquir Immune Defic Syndr; 2018 Nov; 79(3):394-398. PubMed ID: 30063647
[TBL] [Abstract][Full Text] [Related]
4. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.
Pereyra F; Addo MM; Kaufmann DE; Liu Y; Miura T; Rathod A; Baker B; Trocha A; Rosenberg R; Mackey E; Ueda P; Lu Z; Cohen D; Wrin T; Petropoulos CJ; Rosenberg ES; Walker BD
J Infect Dis; 2008 Feb; 197(4):563-71. PubMed ID: 18275276
[TBL] [Abstract][Full Text] [Related]
5. Plasmatic Levels of IL-18, IP-10, and Activated CD8
Côrtes FH; de Paula HHS; Bello G; Ribeiro-Alves M; de Azevedo SSD; Caetano DG; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
Front Immunol; 2018; 9():1576. PubMed ID: 30050532
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers.
Gonzalo-Gil E; Ikediobi U; Sutton RE
Yale J Biol Med; 2017 Jun; 90(2):245-259. PubMed ID: 28656011
[TBL] [Abstract][Full Text] [Related]
7. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
[TBL] [Abstract][Full Text] [Related]
9. Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
Julg B; Pereyra F; Buzón MJ; Piechocka-Trocha A; Clark MJ; Baker BM; Lian J; Miura T; Martinez-Picado J; Addo MM; Walker BD
Clin Infect Dis; 2010 Jul; 51(2):233-8. PubMed ID: 20550452
[TBL] [Abstract][Full Text] [Related]
10. A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers.
Tomescu C; Liu Q; Ross BN; Yin X; Lynn K; Mounzer KC; Kostman JR; Montaner LJ
PLoS One; 2014; 9(7):e103209. PubMed ID: 25078947
[TBL] [Abstract][Full Text] [Related]
11. Modification of the HIV-specific CD8+ T-cell response in an HIV elite controller after chikungunya virus infection.
Ghiglione Y; Ruiz MJ; Salido J; Trifone C; Sued O; Martin Y; Patterson P; Laufer N; Turk G
AIDS; 2016 Jul; 30(12):1905-11. PubMed ID: 27124898
[TBL] [Abstract][Full Text] [Related]
12. T Cell Homeostasis Disturbances in a Cohort of Long-Term Elite Controllers of HIV Infection.
Benito JM; Jiménez-Carretero D; Restrepo C; Ligos JM; Valentín-Quiroga J; Mahillo I; Cabello A; López-Collazo E; Sánchez-Cabo F; Górgolas M; Estrada V; Rallón N;
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892124
[TBL] [Abstract][Full Text] [Related]
13. Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection.
Pernas M; Tarancón-Diez L; Rodríguez-Gallego E; Gómez J; Prado JG; Casado C; Dominguez-Molina B; Olivares I; Coiras M; León A; Rodriguez C; Benito JM; Rallón N; Plana M; Martinez-Madrid O; Dapena M; Iribarren JA; Del Romero J; García F; Alcamí J; Muñoz-Fernández M; Vidal F; Leal M; Lopez-Galindez C; Ruiz-Mateos E
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212942
[TBL] [Abstract][Full Text] [Related]
14. Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers.
Taborda NA; Cataño JC; Delgado JC; Rugeles MT; Montoya CJ
J Acquir Immune Defic Syndr; 2012 May; 60(1):12-9. PubMed ID: 22240462
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
Vigneault F; Woods M; Buzon MJ; Li C; Pereyra F; Crosby SD; Rychert J; Church G; Martinez-Picado J; Rosenberg ES; Telenti A; Yu XG; Lichterfeld M
J Virol; 2011 Mar; 85(6):3015-9. PubMed ID: 21177805
[TBL] [Abstract][Full Text] [Related]
16. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.
Pereyra F; Palmer S; Miura T; Block BL; Wiegand A; Rothchild AC; Baker B; Rosenberg R; Cutrell E; Seaman MS; Coffin JM; Walker BD
J Infect Dis; 2009 Sep; 200(6):984-90. PubMed ID: 19656066
[TBL] [Abstract][Full Text] [Related]
17. Rate and predictors of progression in elite and viremic HIV-1 controllers.
Leon A; Perez I; Ruiz-Mateos E; Benito JM; Leal M; Lopez-Galindez C; Rallon N; Alcami J; Lopez-Aldeguer J; Viciana P; Rodriguez C; Grau E; Iribarren J; Gatell JM; Garcia F;
AIDS; 2016 May; 30(8):1209-20. PubMed ID: 26854807
[TBL] [Abstract][Full Text] [Related]
18. HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.
Owen RE; Heitman JW; Hirschkorn DF; Lanteri MC; Biswas HH; Martin JN; Krone MR; Deeks SG; Norris PJ;
AIDS; 2010 May; 24(8):1095-105. PubMed ID: 20400885
[TBL] [Abstract][Full Text] [Related]
19. Cytokine and Chemokine Signature in Elite Versus Viremic Controllers Infected with HIV.
Platten M; Jung N; Trapp S; Flossdorf P; Meyer-Olson D; Schulze Zur Wiesch J; Stephan C; Mauss S; Weiss V; von Bergwelt-Baildon M; Rockstroh J; Fätkenheuer G; Lehmann C
AIDS Res Hum Retroviruses; 2016 Jun; 32(6):579-87. PubMed ID: 26751176
[TBL] [Abstract][Full Text] [Related]
20. Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil.
Gomes STM; Gomes ÉR; Dos Santos MB; Lima SS; Queiroz MAF; Machado LFA; Cayres-Vallinoto IMV; Vallinoto ACR; de O Guimarães Ishak M; Ishak R
BMC Infect Dis; 2017 Jun; 17(1):381. PubMed ID: 28571570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
